Ctx Life Sciences Api Metoprolol Succinate

FDA Filings

This page includes the latest FDA filings for Ctx Life Sciences Api Metoprolol Succinate. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Registration(s)

FDA Filings

Device
Company
DeviceDate
BluePoint Laboratories, Cipla USA Inc., Cipla Limited- Indore
Prescription Medication2023-08-09
BluePoint Laboratories, Cipla USA Inc., Cipla Limited- Indore
Prescription Medication2023-05-13
Cipla USA Inc., CTX life sciences-API metoprolol succinate, Cipla Ltd. Indore, Moehs Catalana S.L
Prescription Medication2023-04-13
BluePoint Laboratories, Cipla USA Inc., Cipla Limited- Indore
Prescription Medication2023-02-02
BluePoint Laboratories, Cipla USA Inc., Cipla Limited- Indore
Prescription Medication2022-11-15
BluePoint Laboratories, Cipla USA Inc., Cipla Limited- Indore
Prescription Medication2022-09-30
Cipla USA Inc., CTX life sciences-API metoprolol succinate, Cipla Ltd. Indore, Moehs Catalana S.L
Prescription Medication2022-03-10
BluePoint Laboratories, Cipla USA Inc., Cipla Limited- Indore
Prescription Medication2021-01-19
Cipla USA Inc., CTX life sciences-API metoprolol succinate, Cipla Ltd. Indore, Moehs Catalana S.L
Prescription Medication2021-01-14
Cipla USA Inc., CTX life sciences-API metoprolol succinate, Cipla Ltd. Indore, Moehs Catalana S.L
Prescription Medication2019-03-25

Similar & Related FDA Registered Companies

Related Finance Registrations
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.